Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...

On Friday, Immunic Inc (IMUX) stock saw a decline, ending the day at $1.19 which represents a decrease of $-0.02 or -1.65% from the prior close of $1.21. The stock opened at $1.21 and touched a low of ...

Leerink Partners has recently resumed Immunic Inc (IMUX) stock to Outperform rating, as announced on September 9, 2024, according to Finviz. Earlier, on August 27, 2024, B. Riley Securities had ...

Many studies have revealed links between EBV and conditions like MS, an autoimmune disease affecting the brain and spinal cord. EBV is also suspected to play a role in autoimmune diseases such as ...

Faisal Khurshid, an analyst from Leerink Partners, has initiated a new Buy rating on Zura Bio (ZURA). Faisal Khurshid has given his Buy rating ...

Picnic, a leading quality media platform, has today launched significant findings in its newly released Media Quality Report 2024, powered by its proprietary PIQ intelligence. After reviewing over 30, ...

Breckenridge Brewery, a subsidiary of Tilray Brands, Inc. , today announced an exciting collaboration with the University of Colorado Athletics to bring fans a special edition of its beloved Juice ...

The volatility ratio for the week is 6.26%, and the volatility levels for the last 30 days are 8.40% for Immunic Inc The simple moving average for the last 20 days is -14.86% for IMUX stock, with a ...

After hours: 1 November at 19:55 GMT-4 ...